Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 718

Sort by

Sort Order Select

Journal Articles

Effect of Dasatinib Vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized, Open-Label, Multicenter Study of the Chinese Children's Cancer Group

Blood (2019) 134 (Supplement_1): 828.

https://doi.org/10.1182/blood-2019-126219

Published: 2019

Journal Articles

Achievement of Complete Remission (CR) with Measurable Residual Disease (MRD) Negativity Is Highly Prognostic in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) Receiving First Salvage Chemotherapy

Blood (2019) 134 (Supplement_1): 735.

https://doi.org/10.1182/blood-2019-122779

Published: 2019

Journal Articles

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Leonard Naymagon, MD, Douglas Tremblay, MD, Nicole Zubizarreta, MPH, Erin Moshier, MS, Thomas Schiano, MD, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 1154.

https://doi.org/10.1182/blood-2019-124042

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Multicentre Genome Wide Association Study Identifies Risk Alleles for Progressive Chronic Lymphocytic Leukaemia

Blood (2019) 134 (Supplement_1): 1740.

https://doi.org/10.1182/blood-2019-122037

Published: 2019

Journal Articles

Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes

Heather Personett May, PharmD, Erin F Barreto, PharmD, Kristin C. Mara, MS., Kristen McCullough, PharmD, Nelson Leung, MD, Thomas M. Habermann, MD

Blood (2019) 134 (Supplement_1): 1628.

https://doi.org/10.1182/blood-2019-131149

Published: 2019

Journal Articles

Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Somedeb Ball, MD, Tapas Ranjan Behera, Sariya Wongsaengsak, MD, Nuvneet Khandelwal, MD, Rajshekhar Chakraborty, MD

Blood (2019) 134 (Supplement_1): 1841.

https://doi.org/10.1182/blood-2019-125464

Published: 2019

Journal Articles

The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial

Blood (2019) 134 (Supplement_1): 2031.

https://doi.org/10.1182/blood-2019-125646

Published: 2019

Journal Articles

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Sunny R K Singh, MD, Sindhu Malapati, MD, Rohit Kumar, MD, Olekdandra Lupak, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2132.

https://doi.org/10.1182/blood-2019-127604

Published: 2019

Journal Articles

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Christopher E. Wee, MD, Jilan Kubusek, PharmD, Irbaz Riaz, MDMMSc, Robert Wolf, PharmD, RPh, Julian R Molina, MD PhD, Naseema Gangat, MBBS

Blood (2019) 134 (Supplement_1): 2138.

https://doi.org/10.1182/blood-2019-127367

Published: 2019

Journal Articles

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Ahmed Toure, BA, Yiyuan Wu, MS, Paul J Christos, Dr.P.H., M.S., Peter Martin, FRCPC, MD MS

Blood (2019) 134 (Supplement_1): 2205.

https://doi.org/10.1182/blood-2019-131567

Published: 2019

Journal Articles

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Joseph Maakaron, MD, Qiuhong Zhao, MS, Marcin Puto, PharmD, Quinn Verfurth, Sam Penza, MD, Jonathan E Brammer, MD, Yvonne A. Efebera, MD MPH, Ashley E. Rosko, MD, Ayman Saad, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD

Blood (2019) 134 (Supplement_1): 2024.

https://doi.org/10.1182/blood-2019-126994

Published: 2019

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Anca Prica, MD, Ryan D. Morin, PhD, Vishal Kukreti, MD, Robert Kridel, MDMPH,PhD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, Miguel Alcaide, Rashmi S. Goswami, MD PhD, Jan Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, MBChB, PhD, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 2027.

https://doi.org/10.1182/blood-2019-131818

Published: 2019

Journal Articles

In-Hospital Outcomes in Elderly Acute Myeloid Leukemia (AML) Receiving Aggressive Inpatient Care: An Analysis of National Inpatient Sample (NIS) Database between Years 2005 and 2014

Sindhu Malapati, MD, Sunny R K Singh, MD, Rohit Kumar, MD, Jibran Ahmed, MD, Ishaan Vohra, MD, Vatsala Katiyar, MD

Blood (2019) 134 (Supplement_1): 2149.

https://doi.org/10.1182/blood-2019-121439

Published: 2019

Journal Articles

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Christopher Cipkar, MD BSc, Sujitha Srinathan, Philip Chiang, BMSc, Lana A Castellucci, MD FRCPC, MSc

Blood (2019) 134 (Supplement_1): 3668.

https://doi.org/10.1182/blood-2019-131769

Published: 2019

Journal Articles

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Yimin Pearl Wang, BSc, Rohan Kehar, MDMSc,FRCPC, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 3672.

https://doi.org/10.1182/blood-2019-123870

Published: 2019

Journal Articles

Venous Thromboembolism Prophylaxis in Acute Medically Ill Patients: A Retrospective Cohort Study

Anat Gafter-Gvili, MD, Genady Drozdinsky, Oren Zusman, MD, Shiri Kushnir, Leonard Leibovici, MD

Blood (2019) 134 (Supplement_1): 3678.

https://doi.org/10.1182/blood-2019-124495

Published: 2019

Journal Articles

Incidence and Risk Factors of Arterial Thromboembolism in Non-Small Cell Lung Cancer

Avi Leader, MD, Oded Icht, MD, Erez Batat, Uri Rozovski, MD, Lilach Joseph, Tzippy Shochat, Daniel A Goldstein, MD, Elizabeth Dudnik, MD, Baruch Brenner, MD, Pia Raanani, MD, Galia Spectre, Hammerman Ariel, PhD, Alona Zer, MD

Blood (2019) 134 (Supplement_1): 3654.

https://doi.org/10.1182/blood-2019-128822

Published: 2019

Journal Articles

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Paige May, PharmD, Preetika Pai, PharmD, Katherine Boles, PharmD, BCPS, Ashley McGee, PharmD, MBA, BCOP, Jess David Delaune, MD, Tanaka Dang, BS, Jessica M. Schmit, MD

Blood (2019) 134 (Supplement_1): 3538.

https://doi.org/10.1182/blood-2019-130709

Published: 2019

Journal Articles

Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial

Deborah M Siegal, MD, Emilie Belley-Cote, MDMSc FRCPC, Donald M. Arnold, MD, Frederick D'Aragon, MD, Hill Stephen, PhD, Shun Fu Lee, PhD, Tara Pinto, BSc, Bram Rochwerg, MDMSc, Stuart J. Connolly, MD MSc, FRCPC, Ryan Zarychanski, MDMSc, Mark Crowther, MD

Blood (2019) 134 (Supplement_1): 3685.

https://doi.org/10.1182/blood-2019-130257

Published: 2019

NARROW

Effect of Dasatinib Vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized, Open-Label, Multicenter Study of the Chinese Children's Cancer Group

Achievement of Complete Remission (CR) with Measurable Residual Disease (MRD) Negativity Is Highly Prognostic in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) Receiving First Salvage Chemotherapy

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Multicentre Genome Wide Association Study Identifies Risk Alleles for Progressive Chronic Lymphocytic Leukaemia

Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes

Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

In-Hospital Outcomes in Elderly Acute Myeloid Leukemia (AML) Receiving Aggressive Inpatient Care: An Analysis of National Inpatient Sample (NIS) Database between Years 2005 and 2014

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Venous Thromboembolism Prophylaxis in Acute Medically Ill Patients: A Retrospective Cohort Study

Incidence and Risk Factors of Arterial Thromboembolism in Non-Small Cell Lung Cancer

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only